Hepatitis C Treatment: The Data Flood Goes on—An Update From the Liver Meeting 2014
- 1 March 2015
- journal article
- review article
- Published by Elsevier in Gastroenterology
- Vol. 148 (3) , 468-479
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- An Interferon-free Antiviral Regimen for HCV after Liver TransplantationNew England Journal of Medicine, 2014
- Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised studyThe Lancet, 2014
- EASL Recommendations on Treatment of Hepatitis C 2014Journal of Hepatology, 2014
- ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with CirrhosisNew England Journal of Medicine, 2014
- Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without CirrhosisNew England Journal of Medicine, 2014
- New Hepatitis C Therapies: The Toolbox, Strategies, and ChallengesGastroenterology, 2014
- New Hepatitis C Virus (HCV) Drugs and the Hope for a Cure: Concepts in Anti-HCV Drug DevelopmentSeminars in Liver Disease, 2014
- Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV InfectionNew England Journal of Medicine, 2014
- Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment OptionsNew England Journal of Medicine, 2013
- Nucleotide Polymerase Inhibitor Sofosbuvir plus Ribavirin for Hepatitis CNew England Journal of Medicine, 2013